| Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects. | |
| | |
MedLine Citation:
|
PMID: 20090429 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Angiotensin-converting enzyme (ACE) inhibitors are being widely used as antihypertensives by clinicians worldwide. One in every three Americans has hypertension. Hypertension, diabetes, obesity, active smoking, hypercholesterolemia, and inactivity are the major cardiovascular risk factors, which can produce compounding effects on human health, leading to cardiovascular morbidity and mortality. We review the mechanism of action of ACE inhibitors and explain the rationale for using ACE inhibitors not only in hypertensive patients but also in patients with congestive heart failure, acute myocardial infarction, or coronary artery disease. ACE inhibitors can reduce preload and afterload on the heart, prevent ventricular remodeling, and even retard atherogenic changes in the vessel walls. ACE inhibitors can also be helpful in slowing the progression of kidney disease, especially in diabetics. Some studies such as the Heart Outcomes Prevention Evaluation study have shown that ACE inhibitors can reduce the risk of cardiovascular morbidity and mortality, particularly in high-risk individuals. The renin-angiotensin-aldosterone system plays an important role in regulating blood pressure and body volume in the human body. ACE inhibitors and angiotensin-receptor blockers are the two classes of antihypertensives that primarily act on the renin-angiotensin-aldosterone system. We discuss randomized, controlled trials that evaluated different ACE inhibitors and compare them with angiotensin-receptor blockers. |
| | |
Authors:
|
Srikanth Katragadda; Rohit R Arora |
Related Documents
:
|
19379059 - Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascu... 7484889 - Disparate effects of antihypertensive drugs on large artery distensibility and complian... 6266379 - Vasoactive peptides and hypertension: role of angiotensin converting enzyme. 15824469 - Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats. 3555589 - Captopril in combination with hydrochlorothiazide: comparative efficacy vs perceived be... 3038419 - Role of endogenous angiotensin ii and prostaglandins in the antihypertensive mechanism ... 15931959 - Long-term atmospheric mercury wet deposition at underhill, vermont. 8064099 - Postprandial hypotension in 499 elderly persons in a long-term health care facility. 19361899 - A rotating inlay decreases contact pressure on inlay post after posterior cruciate subs... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: American journal of therapeutics Volume: 17 ISSN: 1536-3686 ISO Abbreviation: Am J Ther Publication Date: 2010 Jan-Feb |
Date Detail:
|
Created Date: 2010-01-21 Completed Date: 2010-03-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9441347 Medline TA: Am J Ther Country: United States |
Other Details:
|
Languages: eng Pagination: e11-23 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Chicago Medical School, North Chicago, IL, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin II Type 1 Receptor Blockers
/
pharmacology,
therapeutic use Angiotensin-Converting Enzyme Inhibitors / pharmacology*, therapeutic use Antihypertensive Agents / pharmacology, therapeutic use Heart Diseases / drug therapy*, physiopathology Humans Hypertension / drug therapy*, epidemiology, physiopathology Randomized Controlled Trials as Topic Renin-Angiotensin System / drug effects Risk Factors United States / epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Challenges and recommendations for placebo controls in randomized trials in physical and rehabilitat...
Next Document: Combination therapy in hypertension: a focus on Angiotensin receptor blockers and calcium channel bl...